drugset / Trial / NCT02712788

Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

NCT02712788

Phase 2 Terminated 4 enrolled Indiana University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the usefulness of adding Milrinone to the current standard treatment for cerebral vasospasm.

Timeline

Start
2016-04-18
Primary completion
2017-10-24
Completion
2018-05-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milrinone Small molecule 0.75 ug/kg Intravenous